E-mail: bd@sidmexinovia.com
Telefone: +918866862020
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Hemofil-M 250IU Injection
Manufacturer/Marketed By : BAXALTA BIOSCIENCE INDIA PVT LTD
$37.15 $35.30
Hemofil-M 250IU Injection is an antihemophilic medicine in the class of miscellaneous coagulation modifiers containing the active ingredient Factor VIII. It is used to treat and prevent bleeding in individuals...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
FACTOR VIII
Active Pharmaceutical Ingredient
Hemofil-M 250IU Injection
US$ 37,15
US$ 35,30
Hemofil-M 250IU Injection is an antihemophilic medicine in the class of miscellaneous coagulation modifiers containing the active ingredient Factor VIII. It is used to treat and prevent bleeding in individuals with hemophilia A, a genetic disorder caused by a deficiency or dysfunction of factor VIII, a clotting protein in the blood. This drug is contraindicated in individuals with known hypersensitivity or allergy to it or its component. Stop taking this tablet and contact your doctor immediately if you develop a rash or skin symptoms. The use of this drug increases the cardiovascular risk. It is highly advised to discuss with your physician if you have any existing heart disease condition before initiating the treatment with Hemofil-M 250IU Injection. A central venous access device (CVAD) may sometimes be required to administer this drug treatment. It's important to consider the risks associated with CVAD-related complications, including local infections, bacteremia (bacterial infection in the bloodstream), and catheter site thrombosis (blood clot formation at the catheter site). Proper care and monitoring should be exercised to minimize these risks. The development of inhibitors (antibodies) is a known complication that can occur during treatment with this medicine. These inhibitors can interfere with the effectiveness of the treatment. Patients receiving Hemofil-M 250IU Injection therapy should be closely monitored for the development of inhibitors. If bleeding is uncontrolled with this drug, you must notify your doctor immediately. If you are pregnant or breastfeeding, consult your doctor for more advice before starting the treatment with this drug.
Active Pharmaceutical Ingredient
Usos
• Treatment of Hemophilia A
Benefícios
By facilitating the clotting process, Hemofil-M 250IU injection helps prevent and control bleeding episodes in individuals with hemophilia A and other conditions associated with low factor VIII levels. It reduces the chance of complications such as bleeding, excessive blood loss, and related health issues
Efeitos colaterais
Side Effects are unwanted symptoms caused by medicines. Although all medicines cause side effects, not everyone gets them.
Efeitos colaterais mais comuns
• Reddening of the skin
• Burning and stinging at the injection site
• Chills
• Flushing
• Headache
• Hives
• Hypotension
• Lethargy
• Nausea
• Restlessness
• Tachycardia
• Tightness of the chest
• Tingling
• Vomiting
• Wheezing
Efeitos colaterais comuns
• Allergic reaction (anaphylactic shock) or a hypersensitivity reaction
Como usar
Hemofil-M 250IU Injection is usually administered through a vein (intravenously) by your physician in a hospital setting. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition. Do not self-administer this injection.
Conselhos de segurança
• Breast Feeding: If breastfeeding, consult your doctor before starting the treatment with Hemofil-M 250IU Injection.
• Alcohol: It is unknown whether consuming alcohol while taking Hemofil-M 250IU Injection is safe. Please speak with your physician.
• Liver: It is unknown whether Hemofil-M 250IU Injection is safe for patients with liver problems. Inform your doctor if you have the liver disease before starting the treatment.
• Lungs: It is unknown whether Hemofil-M 250IU Injection is safe for patients with lung problems. Notify your doctor if you have lung disease before starting the treatment.
• Driving: Hemofil-M 250IU Injection does not affect your ability to drive and operate heavy machinery. Inform your physician if you face any symptoms that alter your concentration.
• Pregnancy: If you are pregnant, suspecting, or planning for the pregnancy, ask your doctor for more advice before starting the treatment with Hemofil-M 250IU Injection.
Isenção de responsabilidade
A Sidmex Inovia se esforça para fornecer informações precisas e confiáveis; no entanto, todo o conteúdo deste site, incluindo descrições e composições de produtos, tem caráter meramente informativo e não deve ser considerado um substituto para aconselhamento, diagnóstico ou tratamento médico profissional.
Recomenda-se aos usuários que consultem um profissional de saúde qualificado antes de tomar qualquer decisão médica. As informações fornecidas não devem ser usadas para autodiagnóstico ou automedicação.
Todos os produtos listados destinam-se estritamente a consultas B2B e em grandes quantidades. A Sidmex Inovia não promove o uso direto pelo consumidor e visa apoiar, e não substituir, a relação entre o profissional de saúde e o paciente.
Os nomes de produtos, marcas comerciais e marcas pertencem aos seus respectivos proprietários, e seu uso não implica qualquer afiliação ou endosso. A Sidmex Inovia não se responsabiliza por quaisquer consequências decorrentes do uso das informações fornecidas neste site.